(0.13%) 5 161.50 points
(0.13%) 38 881 points
(0.09%) 18 017 points
(0.84%) $78.77
(0.42%) $2.15
(0.98%) $2 331.30
(2.60%) $27.38
(0.47%) $969.80
(0.04%) $0.929
(-0.20%) $10.85
(-0.18%) $0.796
(0.09%) $91.54
3 days till quarter result
(amc 2024-05-09)
Expected move: +/- 7.02%
0.06% $ 9.10
Live Chart Being Loaded With Signals
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States...
Stats | |
---|---|
Volumen de hoy | 5.56M |
Volumen promedio | 5.66M |
Capitalización de mercado | 1.20B |
EPS | $0 ( 2024-03-04 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -16.84 |
ATR14 | $0.183 (2.01%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-26 | Bvf Partners L P/il | Sell | 43 139 | Common Stock, par value $0.001 |
2023-06-26 | Bvf Partners L P/il | Sell | 12 | Series X Convertible Preferred Stock |
2023-06-26 | Bvf Partners L P/il | Sell | 17 | Series X1 Convertible Preferred Stock |
2023-06-26 | Bvf Partners L P/il | Sell | 120 000 | Stock Option (Right to Buy) |
2023-06-26 | Bvf Partners L P/il | Sell | 60 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
-81.71 |
Last 99 transactions |
Buy: 2 253 317 | Sell: 15 023 868 |
Volumen Correlación
CTI Biopharma Corp Correlación
10 Correlaciones Más Positivas | |
---|---|
ICPT | 0.988 |
SIGA | 0.964 |
DRNA | 0.957 |
EVLV | 0.956 |
SGTX | 0.956 |
IZEA | 0.952 |
BOXL | 0.95 |
CELH | 0.947 |
TWLVU | 0.946 |
QFIN | 0.946 |
10 Correlaciones Más Negativas | |
---|---|
TACT | -0.972 |
LUNA | -0.971 |
ATAK | -0.968 |
ITI | -0.951 |
SBNYP | -0.938 |
MBIN | -0.937 |
CPRX | -0.928 |
VRCA | -0.928 |
TTCF | -0.927 |
INOD | -0.922 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
CTI Biopharma Corp Correlación - Moneda/Commodity
CTI Biopharma Corp Finanzas
Annual | 2022 |
Ingresos: | $53.95M |
Beneficio Bruto: | $50.43M (93.49 %) |
EPS: | $-0.790 |
FY | 2022 |
Ingresos: | $53.95M |
Beneficio Bruto: | $50.43M (93.49 %) |
EPS: | $-0.790 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.090 |
FY | 2020 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.740 |
Financial Reports:
No articles found.
CTI Biopharma Corp
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Baxalta. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico